尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Warnecke Steve B, 董事长兼首席执行官. Officer active across 2 companies, notably Evolutionary Genomics, INC.. Cumulatively, 3 reports have been logged. History available since 19 May 2021. The latest transaction was disclosed on 19 May 2021 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Steve B. Warnecke is the Chairman & CEO of Evolutionary Genomics, Inc. In this role, he is responsible for the strategic and operational direction of the company. Evolutionary Genomics specializes in genomic technologies. Mr. Warnecke's experience in the biotechnology sector is essential for the company's growth and innovation.